Blood Flow Restriction and Creatine Supplementation in Women
Status
Completed
Conditions
Physical Inactivity
Treatments
Dietary Supplement: Creatine Monohydrate
Other: Exercise
Device: Blood Flow Restriction
Details and patient eligibility
About
This research is examining the changes in muscle size, muscle function, body composition, strength, and blood vessel health. Specifically, the changes in these variables over the course of 8 weeks of training with or without blood flow restriction (BFR) and the supplementation of creatine or placebo (dextrose, a sugar in the form of a powder which is the standard placebo). Creatine monohydrate (Cr) is the most popular supplement for athletes and benefits all populations, however women are still very hesitant to take it due to the misconception of weight gain. This study will look to measure those muscle and body changes with exercise.
Full description
We expect that you will be in this research study for an estimated 10 weeks, with 27 visits total. You will be asked to complete questionnaires, blood draws, and perform exercises using exercise machines for testing the strength of your legs while using a blood pressure cuff during some of these exercises. Other tests in this study will measure hydration (water in your system) status, your nervous system, and body composition percentage (bone/muscle tissue/fat tissue). Specifically, you will be asked to attend:
- 1 consent visit with familiarization (60min)
- 1 baseline assessment with a blood sample (60min)
- 1 baseline strength assessment (45min)
- 2 creatine supplementation loading day visits (15min)
- 1 post loading assessment with a blood sample (60min)
- 1 post loading strength assessment (45min)
- 16 training days (60min each) two of which will have blood samples (+70min)
- 1-4wk follow up assessment (45min)
- 1 4wk follow up strength assessment (45min)
- 1 posttest assessment (45min)
- 1 posttest strength assessment (45min)
Enrollment
68 patients
Sex
Female
Ages
18 to 35 years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- Are female between the ages of 18 to 35
- Recreationally active, defined as meeting the ACSM standards for recreationally active individuals of participating in physical activity ≥ 150 minutes exercise/week.
- Not following a resistance training program
- Are Not currently taking creatine monohydrate or have not taken it in the last 6 weeks
- No known cardiovascular, pulmonary, metabolic, muscular, and/or coronary heart disease (i.e. heart failure, diabetes, COPD, etc.)
- Do not regularly use prescription medication (not including contraceptives)
- Are not currently seeking medical care.
- Are not currently pregnant.
Exclusion criteria
- Taking creatine or has taken creatine in the last 6 weeks
- Currently resistance training
- Pregnant
Trial design
Primary purpose
Basic Science
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
Double Blind
68 participants in 5 patient groups, including a placebo group
Control
No Intervention group
Description:
If you are in the control group, there will be no supplement or exercise procedures.
You will be asked to come in to the lab for 5 visits
Creatine and Blood Flow Restriction Exercise
Experimental group
Description:
* Of the other four groups, regardless of randomization, all 4 groups will be supplementing the same for the loading phase and throughout the study. Since this study is blinded, the research personnel will not know which supplement you are given and will therefore ensure everyone is following the same procedures.
* Loading here means to consume more than the daily amount of supplement. This visit will have participants consume 5g twice in one day and twice more at home. This is a normal practice and standard use of the supplement.
* If you are not in the control group, you will further be randomized into one of four possible supplementation groups. These groups will be double blinded and randomized into either placebo or creatine supplementation. Creatine monohydrate powder (Muscle Feast, Creapure®) will be used for the active supplement group. Dextrose powder (sugar) will be used for the placebo group.
* The supplement and placebo are flavorless and odorless powder.
Treatment:
Device: Blood Flow Restriction
Dietary Supplement: Creatine Monohydrate
Creatine and No-BFR with Training
Active Comparator group
Description:
* Of the other four groups, regardless of randomization, all 4 groups will be supplementing the same for the loading phase and throughout the study. Since this study is blinded, the research personnel will not know which supplement you are given and will therefore ensure everyone is following the same procedures.
* Loading here means to consume more than the daily amount of supplement. This visit will have participants consume 5g twice in one day and twice more at home. This is a normal practice and standard use of the supplement.
* If you are not in the control group, you will further be randomized into one of four possible supplementation groups. These groups will be double blinded and randomized into either placebo or creatine supplementation. Creatine monohydrate powder (Muscle Feast, Creapure®) will be used for the active supplement group. Dextrose powder (sugar) will be used for the placebo group.
* The supplement and placebo are flavorless and odorless powder.
Treatment:
Dietary Supplement: Creatine Monohydrate
Placebo and Blood Flow Restriction Exercise
Placebo Comparator group
Description:
* Of the other four groups, regardless of randomization, all 4 groups will be supplementing the same for the loading phase and throughout the study. Since this study is blinded, the research personnel will not know which supplement you are given and will therefore ensure everyone is following the same procedures.
* Loading here means to consume more than the daily amount of supplement. This visit will have participants consume 5g twice in one day and twice more at home. This is a normal practice and standard use of the supplement.
* If you are not in the control group, you will further be randomized into one of four possible supplementation groups. These groups will be double blinded and randomized into either placebo or creatine supplementation. Creatine monohydrate powder (Muscle Feast, Creapure®) will be used for the active supplement group. Dextrose powder (sugar) will be used for the placebo group.
* The supplement and placebo are flavorless and odorless powder.
Treatment:
Device: Blood Flow Restriction
Placebo and No-BFR with Training
Sham Comparator group
Description:
* Of the other four groups, regardless of randomization, all 4 groups will be supplementing the same for the loading phase and throughout the study. Since this study is blinded, the research personnel will not know which supplement you are given and will therefore ensure everyone is following the same procedures.
* Loading here means to consume more than the daily amount of supplement. This visit will have participants consume 5g twice in one day and twice more at home. This is a normal practice and standard use of the supplement.
* If you are not in the control group, you will further be randomized into one of four possible supplementation groups. These groups will be double blinded and randomized into either placebo or creatine supplementation. Creatine monohydrate powder (Muscle Feast, Creapure®) will be used for the active supplement group. Dextrose powder (sugar) will be used for the placebo group.
* The supplement and placebo are flavorless and odorless powder.
Treatment:
Other: Exercise
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems